Skip to main content
SpringerLink
Log in

Multiple clinical vertebral fractures following denosumab discontinuation

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Aubry-Rozier B, Gonzalez-Rodriguez E, Stoll D, Lamy O (2015) Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports. Osteoporos Int

  2. Brown JP, Roux C, Törring O et al (2013) Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial. J Bone Miner Res 28:746–752

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bone HG, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwinski E, Fahrleitner-Pammer A, Kendler DL, Lippuner K, Reginster J-Y, Roux C, Vittinghoff E, Daizadeh NS, Wang A, Dakin P, Wagman, Papapoulos S. Ten years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension trial. Annual meeting of the American Society for Bone and Mineral Research (ASBMR), October 9–12, 2015, Seattle, USA

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, 424 General Military Hospital, Ring Road, 564 29 N.Efkarpia, Thessaloniki, Greece

    A. D. Anastasilakis

  2. Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece

    P. Makras

Authors
  1. A. D. Anastasilakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Makras
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. D. Anastasilakis.

Ethics declarations

Conflicts of interest

A.D. Anastasilakis has received lecture fees and research grants from Amgen and lecture fees from Bianex, Eli-Lilly, and ITF; P. Makras has received lecture fees and research grants from Amgen and lecture fees from Pfizer, Leo, Genesis, ELPEN, UniPharma, Bianex.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anastasilakis, A.D., Makras, P. Multiple clinical vertebral fractures following denosumab discontinuation. Osteoporos Int 27, 1929–1930 (2016). https://doi.org/10.1007/s00198-015-3459-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-015-3459-5

Keywords

Search

Navigation